Third Rock Ventures III, L.P.

Average Profitability
2.11%
Insider Buys Quantity
1
Insider Buys Sum
$2.6M
Insider Sells Quantity
11
Insider Sells Sum
$461.11M

Insider Activity of Third Rock Ventures III, L.P.

The largest purchase of all time was on 2019-07-22 and amounted to 162500 shares of Fulcrum Therapeutics, Inc. for $2.6M.

The largest sale of all time was on 2021-01-13 and amounted to 4314200 shares of Relay Therapeutics, Inc. for $173.11M.

Biography of Third Rock Ventures III, L.P.

No biography is available at this moment.

2023-02-01SaleVoyager Therapeutics, Inc.
VYGR
10 percent owner
128,642
0.3339%
$9.32$1.2M-14.85%
2023-01-31SaleVoyager Therapeutics, Inc.
VYGR
10 percent owner
185,000
0.4726%
$9.25$1.71M-15.52%
2023-01-30SaleVoyager Therapeutics, Inc.
VYGR
10 percent owner
75,000
0.1947%
$9.03$677,250-11.96%
2023-01-27SaleVoyager Therapeutics, Inc.
VYGR
director
50,000
0.1305%
$9.02$451,000-11.21%
2023-01-25SaleVoyager Therapeutics, Inc.
VYGR
director
50,000
0.1322%
$9.22$461,000-11.83%
2023-01-24SaleVoyager Therapeutics, Inc.
VYGR
director
100,000
0.2549%
$9.27$927,000-15.4%
2023-01-23SaleVoyager Therapeutics, Inc.
VYGR
director
55,000
0.1418%
$9.06$498,300-12.39%
2023-01-20SaleVoyager Therapeutics, Inc.
VYGR
director
100,000
0.2604%
$9.15$915,000-12.34%
2021-01-14SaleRelay Therapeutics, Inc.
RLAY
10 percent owner
3.93M
4.082%
$41.00$161.15M-23.51%
2021-01-13SaleRelay Therapeutics, Inc.
RLAY
10 percent owner
4.31M
4.5696%
$40.13$173.11M-20.24%
2021-01-12SaleRelay Therapeutics, Inc.
RLAY
10 percent owner
3M
3.326%
$40.00$120M-16.2%
2019-07-22PurchaseFulcrum Therapeutics, Inc.
FULC
10 percent owner
162,500
1.1421%
$16.00$2.6M+2.11%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.